Clinical evaluation of individuals who may have a genetic kidney disease: the importance of deep-phenotyping
New concepts of drug-associated AKI
ERAKI Working Group
Speaker
Sandra L. Kane-Gill, USA
Panellists
Sophie De Seigneux, Switzerland
Bairbre McNicholas, Ireland
Moderator
Marlies Ostermann, United Kingdom